Join
Live feed
·
SECFilingvia Quantisnow
Supernus Pharmaceuticals Inc. logo

Supernus Pharmaceuticals Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Completion of Acquisition or Disposition of Assets, Financial Statements and Exhibits

ByQuantisnow·Wall Street's wire, on your screen.
SUPN· Supernus Pharmaceuticals Inc.
Health Care
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track SUPN (Supernus Pharmaceuticals Inc.) and more on Quantisnow.